Brazil‘s health regulator has suspended a clinical trial for China‘s Sinovac coronavirus vaccine citing a severe adverse event, delighting President Jair Bolsonaro, who has criticized it for lacking credibility amid growing geopolitical tensions as the global race for a COVID-19 vaccine continues.Brazil‘s health regulator, Anvisa, said on Tuesday that its decision to suspend trials was purely technical and dismissed any “politicization” of its work to ensure a safe and effective vaccine.“We had no choice but to suspend the trials given the event,” the head of the agency Antônio Barra Torres said at a news conference.
Reuters news agency reported earlier on Tuesday, citing a source familiar with the matter, that the event was the suicide of.